B cells have been shown to promote anti-tumour immunity through the release of inflammatory cytokines, such as IFNγ and IL-12, and directly attack tumour cells via production of granzyme B and TRAIL in hepatocellular carcinoma [117]. This evidence concerns the gene IFNG and neoplasm.